Cephalosporin derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514201, 540221, 540222, 540225, C07D50136, A61K 31545

Patent

active

052329186

ABSTRACT:
Cephalosporin derivatives having a 3-position substituent of formula I are described: ##STR1## wherein R.sup.1 is hydrogen, alkenyl or optionally substituted alkyl, Het is a 5- or 6-membered heterocyclic ring bonded via a carbon atom to the amide linkage, wherein Het is selected from a group of the formulae II-III: ##STR2## wherein A is CH or a nitrogen atom; B is oxygen, sulphur or a group NR.sup.4 ; one or two of D, E, F and G are nitrogen atoms and the remainder are CH groups: or Het is a pyrazinone, pyridinone, pyridazinone or pyrimidinone ring, or is a thione equivalent of such a ring, said rings having a substituent R.sup.4 on one nitrogen atom, or is pyranone, or pyranthione; the ring Het being fused by any two adjacent carbon atoms to the benzene ring; and Het being attached to the --CH.sub.2 NR.sup.1 CO-- group via a carbon atom;

REFERENCES:
patent: 5008259 (1991-04-01), Siret et al.
patent: 5019570 (1991-05-01), Arnould et al.
patent: 5055462 (1991-10-01), Daves et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cephalosporin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cephalosporin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cephalosporin derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2270441

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.